publicationMetadata:
  pmid: "24848258"
  title: "Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship."
  queryType: "bench"  # From PubMed query (hint only)
  publicationType: "Lab Research"
  publicationTypeConfidence: 0.95  # High confidence - mentions cell lines, xenograft models, drug testing
  hasMethodsSection: No
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research â†’ antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    
    This publication describes laboratory research involving:
    - "diverse panel of cancer cell lines" - suggests cell line tools
    - "tumor xenograft models" - suggests animal models/PDX models
    - "blocking antibodies" - suggests antibody tools
    - Drug compounds (VS-4718, pemetrexed, cisplatin) - potential genetic reagents/compounds
    - In vitro and in vivo experimental work
    
    Expected tool types: cell lines, animal models, antibodies, potentially patient-derived models (xenografts)
  overallAssessment: |
    This is clearly a laboratory research publication describing experimental work with cancer cell lines,
    xenograft tumor models, and drug sensitivity testing. The study involves both in vitro cell culture
    experiments and in vivo animal studies. Despite lacking a formal Methods section, the abstract describes
    typical lab research activities that would require multiple research tools including cell lines, animal
    models, antibodies, and potentially patient-derived xenograft models.

toolValidations: []  # No tools were mined to validate

potentiallyMissedTools:
  - toolName: "cancer cell lines"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "In a diverse panel of cancer cell lines, we found that the cells most sensitive to focal adhesion kinase (FAK) inhibition lack expression"
    whyMissed: "Generic term 'cancer cell lines' mentioned but no specific cell line names provided in abstract"
    confidence: 0.8
    shouldBeAdded: Maybe
    
  - toolName: "MPM cells"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "Our data demonstrate that low Merlin expression predicts for increased sensitivity of MPM cells to a FAK inhibitor, VS-4718"
    whyMissed: "MPM (malignant pleural mesothelioma) cells mentioned but no specific cell line names given"
    confidence: 0.7
    shouldBeAdded: Maybe
    
  - toolName: "tumor xenograft models"
    toolType: "patient_derived_model"
    foundIn: "abstract"
    contextSnippet: "Our data demonstrate that low Merlin expression predicts for increased sensitivity of MPM cells to a FAK inhibitor, VS-4718, in vitro and in tumor xenograft models"
    whyMissed: "Xenograft models mentioned but no specific model names or details provided"
    confidence: 0.9
    shouldBeAdded: Yes
    
  - toolName: "blocking antibodies"
    toolType: "antibody"
    foundIn: "abstract"
    contextSnippet: "Disruption of MPM cell-cell or cell-extracellular matrix (ECM) contacts with blocking antibodies suggests that weak cell-cell adhesions"
    whyMissed: "Blocking antibodies mentioned but no specific antibody names or targets specified"
    confidence: 0.8
    shouldBeAdded: Maybe
    
  - toolName: "VS-4718"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "Our data demonstrate that low Merlin expression predicts for increased sensitivity of MPM cells to a FAK inhibitor, VS-4718"
    whyMissed: "Specific FAK inhibitor compound mentioned - this is a research reagent/drug compound"
    confidence: 0.9
    shouldBeAdded: Yes
    
  - toolName: "pemetrexed"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "Whereas pemetrexed and cisplatin, standard-of-care agents for MPM, enrich for CSCs"
    whyMissed: "Specific chemotherapy drug mentioned as research reagent for comparison studies"
    confidence: 0.8
    shouldBeAdded: Maybe
    
  - toolName: "cisplatin"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "Whereas pemetrexed and cisplatin, standard-of-care agents for MPM, enrich for CSCs"
    whyMissed: "Specific chemotherapy drug mentioned as research reagent for comparison studies"
    confidence: 0.8
    shouldBeAdded: Maybe

suggestedPatterns:
  - patternType: "term"
    pattern: "xenograft model[s]?"
    toolType: "patient_derived_model"
    examples: ["tumor xenograft models"]
    reasoning: "Xenograft models are commonly used patient-derived models that should be captured"
    
  - patternType: "term"
    pattern: "blocking antibod(y|ies)"
    toolType: "antibody"
    examples: ["blocking antibodies"]
    reasoning: "Blocking antibodies are functional antibodies used as research tools"
    
  - patternType: "context_phrase"
    pattern: "panel of .* cell lines"
    toolType: "cell_line"
    examples: ["diverse panel of cancer cell lines"]
    reasoning: "Phrases describing cell line panels indicate cell line tool usage"
    
  - patternType: "term"
    pattern: "VS-[0-9]+"
    toolType: "genetic_reagent"
    examples: ["VS-4718"]
    reasoning: "VS-series compounds are specific research reagents/inhibitors that should be captured"
    
  - patternType: "naming_convention"
    pattern: "[A-Z]{2,}\\s+cells"
    toolType: "cell_line"
    examples: ["MPM cells"]
    reasoning: "Acronym followed by 'cells' often indicates specific cell line types"

observations: []  # No validated tools to extract observations from

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 7  # Number of tools that might have been missed
  newPatternsCount: 5  # Number of new patterns suggested
  observationsExtracted: 0  # No validated tools to extract observations from
  observationsByType: {}
  majorIssuesFound: |
    Major issues found during review:
    - No tools were mined from this publication despite clear evidence of laboratory research
    - Abstract-only content limits detailed tool identification (no Methods section available)
    - Multiple potential research tools mentioned but not captured by mining algorithms
    - Specific compounds (VS-4718) and experimental models (xenografts) clearly described but missed
    - Generic terms used (e.g., "cancer cell lines") without specific names make tool identification challenging
  recommendations: |
    Overall recommendations for this publication:
    - This publication clearly describes laboratory research and should contain multiple research tools
    - The mining algorithms appear to have missed several obvious tools mentioned in the abstract
    - Key missed tools include: xenograft models, blocking antibodies, and specific compounds (VS-4718)
    - The lack of Methods section limits detailed tool identification, but abstract provides sufficient evidence
    - Suggest adding patterns for xenograft models, blocking antibodies, and VS-series compounds
    - Consider manual curator review to identify specific cell line names from full text if available
    - This represents a significant false negative case where legitimate research tools were not detected
